M. Carr

发表

The emergence of the metabolic syndrome with menopause.

M. C. Carr, Molly C Carr, M. Carr, 2003, The Journal of clinical endocrinology and metabolism.

Effect of raloxifene on serum triglycerides in women with a history of hypertriglyceridemia while on oral estrogen therapy.

J. Brunzell, P. W. Anderson, M. C. Carr, 2005, Diabetes care.

Varying Cost and Free Nicotinic Acid Content in Over-the-Counter Niacin Preparations for Dyslipidemia

J. Brunzell, M. C. Carr, C. Meyers, 2003, Annals of Internal Medicine.

Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet.

S. Deeb, J. Brunzell, M. C. Carr, 2003, Journal of lipid research.

Efficacy and Safety of the Once-Weekly GLP-1 Receptor Agonist Albiglutide Versus Sitagliptin in Patients With Type 2 Diabetes and Renal Impairment: A Randomized Phase III Study

Lawrence A Leiter, Y. Handelsman, Fred Yang, 2014, Diabetes Care.

Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study.

N. Woods, E. Boyko, M. Wener, 2009, The Journal of clinical endocrinology and metabolism.

HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea

R. Pratley, M. Stewart, M. C. Carr, 2014, Diabetologia.

Increased urinary cortisol levels during the menopause transition

N. Woods, M. C. Carr, E. Mitchell, 2006, Menopause.

Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution DOI 10.1194/jlr.M100373-JLR200

J. Brunzell, H. Kennedy, M. C. Carr, 2002, Journal of Lipid Research.

The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity.

J. Hokanson, S. Deeb, J. Brunzell, 2001, The Journal of clinical endocrinology and metabolism.

Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans: role of central obesity and LIPC polymorphisms.

S. Deeb, J. Brunzell, M. C. Carr, 2004, Journal of lipid research.

A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women.

J. Hokanson, S. Deeb, J. Brunzell, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Lipase Activity With Increasing Intra-abdominal Fat in Women A Hepatic Lipase Gene Promoter Polymorphism Attenuates the Increase in Hepatic

J. Hokanson, S. Deeb, J. Brunzell, 1999 .

PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance.

J. Hokanson, J. Brunzell, M. C. Carr, 2000, Journal of lipid research.

Development of a long‐acting relaxin analogue, LY3540378, for treatment of chronic heart failure

Matthew M. Abernathy, R. Hansen, M. C. Carr, 2023, British journal of pharmacology.

Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.

J. Brunzell, M. C. Carr, Molly C Carr, 2004, The Journal of clinical endocrinology and metabolism.

Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial

J. Rosenstock, P. Home, M. C. Carr, 2020, Diabetes Care.

Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies.

M. Mendelsohn, P. Maki, P. Wise, 2006, Endocrine reviews.

Albiglutide does not impair the counter‐regulatory hormone response to hypoglycaemia: a randomized, double‐blind, placebo‐controlled, stepped glucose clamp study in subjects with type 2 diabetes mellitus

R. Reinhardt, L. Morrow, M. C. Carr, 2015, Diabetes, obesity & metabolism.

Disease Risk Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome : Importance of Society

J. Brunzell, M. C. Carr, M. Carr, 2004 .

Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: HARMONY 5

M. Stewart, P. Home, M. C. Carr, 2015, Diabetes, obesity & metabolism.

Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy.

Diane M. Miller, P. Home, J. Reusch, 2017, Diabetes research and clinical practice.

Albiglutide for the treatment of type 2 diabetes mellitus: An integrated safety analysis of the HARMONY phase 3 trials.

K. Murphy, B. Ahrén, M. C. Carr, 2017, Diabetes research and clinical practice.

Contribution of Hepatic Lipase, Lipoprotein Lipase, and Cholesteryl Ester Transfer Protein to LDL and HDL Heterogeneity in Healthy Women

S. Deeb, J. Brunzell, M. C. Carr, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement.

S. Marcovina, H. Kennedy, M. C. Carr, 2002, Journal of lipid research.